Novartis Ag (NVS) Revenue (2009 - 2024)

Novartis Ag's Revenue history runs 13 years deep, the most recent figure standing at $12.5 billion for Q2 2024.

• In Q2 2024, Revenue fell 52.92% year-over-year to $12.5 billion; the TTM figure through Jun 2024 stood at $35.3 billion (up 32.93% YoY), while the FY2025 annual figure was $54.5 billion, up 8.38% from the prior year.
• Revenue came in at $12.5 billion for Q2 2024 at Novartis Ag, down from $22.2 billion in the prior quarter.
• In the past five years, Revenue ranged from a high of $42.0 billion in Q4 2021 to a low of $226.0 million in Q3 2021.
• A 5-year average of $11.2 billion and a median of $302.5 million in 2021 frame the typical range for Revenue.
• Across the five-year window, Revenue soared 17268.6% in 2021 and sank 99.4% in 2022, its largest moves.
• Novartis Ag's Revenue stood at $242.0 million in 2020, then jumped by 17268.6% to $42.0 billion in 2021, then tumbled by 99.4% to $254.0 million in 2022, then soared by 8653.94% to $22.2 billion in 2023, then tumbled by 43.73% to $12.5 billion in 2024.
• According to Business Quant data, Revenue over the past three periods registered $12.5 billion, $22.2 billion, and $26.6 billion for Q2 2024, Q4 2023, and Q2 2023 respectively.

Peer Comparison